Search results
Plant-based diet may reduce risk of emphysema among smokers
United Press International via Yahoo News· 14 hours agoThe findings, published recently in Chronic Obstructive Pulmonary Diseases: Journal of the COPD...
11 Oversold Growth Stocks to Buy Right Now
Insider Monkey via Yahoo Finance· 1 day agoIn this article, we will take a look at the 11 oversold growth stocks to buy right now. To skip our analysis of the recent trends and market activity,...
MannKind advances new inhaled NTM lung disease treatment By Investing.com
Investing.com· 18 hours agoMannKind (NASDAQ:MNKD) Corporation (NASDAQ:MNKD), a biopharmaceutical company, announced today the...
Sanofi reports 1Q revenue increase, as sales of vaccines, Dupixent rise
WFMZ Eastern Pennsylvania and Western New Jersey· 5 days agoSanofi, a pharmaceutical company with Monroe County operations, reported a 2.4% gain in...
The Lundquist Institute Receives $2.6 Million Grant from U.S. Army Medical Research Acquisition...
Morningstar· 5 days agoThe research project is led by Dr. Harry Rossiter, an investigator at TLI and Professor at the David Geffen School of Medicine at UCLA. The project aims to develop wearable multiplex biosensors ...
RSV vaccine boosts Monroe County's Sanofi Pasteur
WFMZ Eastern Pennsylvania and Western New Jersey· 5 days agoSanofi, a pharmaceutical company with Monroe County operations, reported a 2.4% gain in first-quarter revenue on Thursday, as sales of vaccines and the...
Lucius Partners, LLC Portfolio Company AerWave Medical, Inc. Initiates Patient Screening in...
The Bradford Era· 7 days agoLucius Partners, LLC ("LP") today announced that its portfolio company, AerWave Medical, Inc., has begun screening patients for inclusion in First in Human (FIH) studies of the Company's unique ...
Mold Rash: Everything You Need to Know
Verywell Health via Yahoo News· 6 days agoSome people develop dry, itchy, or scaly skin from a mold allergy. This mold rash is a result of the spores coming into contact with the skin. Here’s how...
Press Release: Sanofi Q1: robust 7% sales growth driven by launches, underpins full-year guidance
Morningstar· 5 days agoSanofi Q1: robust 7% sales growth driven by launches, underpins full-year guidance Paris, April 25, 2024 Sales growth of 6.7% at CER and business EPS(1) of €1.78 Dupixent sales up 24.9% to €2,835 ...
The Cream Of The Crop: 5 Biotechs That Outrank Most Stocks
Investor's Business Daily· 5 days agoThe company is working on a drug to treat liver fibrosis due to hepatitis B and metabolic...